Andhra Medi Pharma India Profile
Key Indicators
- Authorised Capital ₹ 2.25 Cr
- Paid Up Capital ₹ 2.25 Cr
- Company Age 15 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 18.15 Cr
- Revenue Growth -33.17%
- Profit Growth -48.43%
- Ebitda -2.38%
- Net Worth 9.90%
- Total Assets 3.19%
About Andhra Medi Pharma India
Andhra Medi Pharma India Private Limited (AMPIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 26 November 2009 and has a history of 15 years and two months. Its registered office is in Vijayawada, Andhra Pradesh, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.25 Cr and a paid-up capital of Rs 2.25 Cr.
The company currently has active open charges totaling ₹18.15 Cr.
Sirigina Rao, Garikipati Kumar, Burugupalli Srinivas, and Three other members serve as directors at the Company.
Company Details
-
Location
Vijayawada, Andhra Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24233AP2009PTC065969
-
Company No.
065969
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Nov 2009
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Andhra Medi Pharma India?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sirigina Rao
|
Director | 15-Apr-2011 | Current |
|
Garikipati Kumar
|
Director | 15-Apr-2011 | Current |
|
Burugupalli Srinivas
|
Director | 03-Dec-2010 | Current |
|
Anjana Chilakapati
|
Director | 26-Nov-2009 | Current |
|
Rajeev Chilakapati
|
Director | 26-Nov-2009 | Current |
|
Kolathur Srinarayanan
|
Director | 03-Dec-2010 | Current |
Financial Performance of Andhra Medi Pharma India.
Andhra Medi Pharma India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 33.17% decrease. The company also saw a substantial fall in profitability, with a 48.43% decrease in profit. The company's net worth moved up by a moderate rise of 9.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Andhra Medi Pharma India?
In 2021, Andhra Medi Pharma India had a promoter holding of 20.00% and a public holding of 80.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Biofern Life Sciences Private LimitedGarikipati Kumar, Burugupalli Srinivas and 1 more are mutual person
-
Jahnavi Chem Products Private LimitedGarikipati Kumar and Anjana Chilakapati are mutual person
-
Balaji Aqua And Poultry Feed Llp
Burugupalli Srinivas is a mutual person
-
Quantlytix Private Limited
Burugupalli Srinivas is a mutual person
-
Andhra Mariscos Enterprises Private Limited
Burugupalli Srinivas and Kolathur Srinarayanan are mutual person
-
Sri Udbava Infra Developers Private Limited
Anjana Chilakapati and Rajeev Chilakapati are mutual person
Charges (Loans)
₹18.15 Cr
₹0
Charges Breakdown by Lending Institutions
- Indian Bank : 18.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Sep 2022 | Indian Bank | ₹3.50 Cr | Open |
| 14 Jul 2022 | Indian Bank | ₹1.16 Cr | Open |
| 14 Jul 2020 | Indian Bank | ₹9.90 M | Open |
| 20 Apr 2011 | Indian Bank | ₹12.50 Cr | Open |
How Many Employees Work at Andhra Medi Pharma India?
Andhra Medi Pharma India has a workforce of 89 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Andhra Medi Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Andhra Medi Pharma India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.